Medicare Enrolled
Dr. Andrew Ciancimino, M.D.
Internal Medicine · Greenvale, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ciancimino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ciancimino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ciancimino
Dr. Andrew Ciancimino is an internal medicine specialist in Greenvale, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Ciancimino performed 3,387 Medicare services across 2,018 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ciancimino received a total of $3,790 from 27 pharmaceutical and/or device companies across 185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ciancimino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 10% volume in NY
$3,790 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,387
Medicare services
Top 10% in NY for internal medicine
2,018
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~242 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,381 | $71 | $270 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
581 | $108 | $442 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
308 | $149 | $445 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
257 | $8 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
123 | $79 | $313 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
117 | $12 | $52 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
93 | $191 | $570 |
| Annual depression screening | 85 | $22 | $65 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
60 | $79 | $313 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
59 | $36 | $85 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
54 | $73 | $291 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
50 | $32 | $80 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
39 | $13 | $49 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $115 | $447 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
27 | $1 | $7 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
26 | $72 | $283 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
23 | $131 | $218 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
23 | $36 | $76 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $123 | $579 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
18 | $189 | $705 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $77 | $394 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,790
Total received (2020-2024)
Avg $758/year across 5 years
Top 19% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
185
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,790 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,587
2023
$997
2022
$670
2021
$493
2020
$43
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$274
Novartis Pharmaceuticals Corporation
$229
Amgen Inc.
$168
Lilly USA, LLC
$148
PFIZER INC.
$144
Merck Sharp & Dohme LLC
$114
Dexcom, Inc.
$69
ALK-Abello, Inc
$57
VIVUS LLC
$55
Regeneron Healthcare Solutions, Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Exact Sciences Corporation
$50
Abbott Laboratories
$47
Currax Pharmaceuticals LLC
$33
Agios Pharmaceuticals, Inc.
$24
Actelion Pharmaceuticals US, Inc.
$19
Astellas Pharma US Inc
$18
Supernus Pharmaceuticals, Inc.
$16
GlaxoSmithKline, LLC.
$16
Top 3 companies account for 42.3% of 2024 payments
All-time payments by company (2020-2024) ›
Novartis Pharmaceuticals Corporation
$757
Novo Nordisk Inc
$543
Merck Sharp & Dohme LLC
$473
PFIZER INC.
$367
Amgen Inc.
$239
Abbott Laboratories
$173
Lilly USA, LLC
$171
Medtronic, Inc.
$135
ALK-Abello, Inc
$125
Exact Sciences Corporation
$103
Merck Sharp & Dohme Corporation
$91
Dexcom, Inc.
$89
Regeneron Healthcare Solutions, Inc.
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$75
VIVUS LLC
$75
Astellas Pharma US Inc
$40
Daxor Corporation
$34
Currax Pharmaceuticals LLC
$33
Genentech USA, Inc.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$31
Agios Pharmaceuticals, Inc.
$24
RedHill Biopharma Inc.
$20
Actelion Pharmaceuticals US, Inc.
$19
Supernus Pharmaceuticals, Inc.
$16
GlaxoSmithKline, LLC.
$16
Akcea Therapeutics, Inc.
$14
Zealand Pharma US, Inc.
$13
Top 3 companies account for 46.8% of all-time payments
Associated products mentioned in payments ›
BELSOMRA · BVA-100 · CONTRAVE · CardioMEMS HF System · Cologuard Collection Kit · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EVENITY · EVKEEZA · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · INPEN SMART INSULIN DELIVERY SYSTEM · ISENTRESS · InPen · JARDIANCE · LEQVIO · MOUNJARO · Myrbetriq · OPSUMIT · Odactra · Otezla · Ozempic · PAXLOVID · PIFELTRO · PYRUKYND · QSYMIA · Qelbree · RYBELSUS · Repatha · Rybelsus · SHINGRIX · STEGLATRO · TEGSEDI · TRINTELLIX · Talicia · V-GO DISPOSABLE INSULIN DELIVERY · VERQUVO · Veozah · Wegovy · Xofluza · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
9,827
Per 100K population
707.9
County median income
$143,408
Nearest hospital
ST FRANCIS HOSPITAL - THE HEART CENTER
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ciancimino is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NY), with low-engagement industry engagement in the top 19% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ciancimino experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Ciancimino performed 1,381 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ciancimino receive payments from pharmaceutical companies?
Yes. Dr. Ciancimino received a total of $3,790 from 27 companies across 185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ciancimino's costs compare to other internal medicine physicians in Greenvale?
Dr. Ciancimino's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ciancimino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Greenvale
Browse internal medicine physicians in Greenvale ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology